Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115133) titled 'Safety and Efficacy of Butylphthalide Soft Capsules for Cognitive Impairment Comorbid with Focal Epilepsy in Elderly Patients: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial' on Dec. 23, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Wenzhou Medical University
Condition:
Cognitive impairment comorbid with focal epilepsy in elderly patients
Intervention:
Butylphthalide Treatment Group: DL-3-n-butylphthalide soft capsules 0.1g per capsule, 2 capsules (0.2g) three times daily, taken orally after meals, continuously for 48 week...